Evidence map›Paper›PMID 33364967›Full record

ArticleFrontiers in pharmacology2020

Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.

Jinmei Su, Mengtao Li, Lan He, Dongbao Zhao, Weiguo Wan, Yi Liu, Jianhua Xu, Jian Xu, Huaxiang Liu, Lindi Jiang and 20 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 1 country.

Jinmei SuDepartment of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Ministry of Science and Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Mengtao LiDepartment of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Ministry of Science and Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Lan HeDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Dongbao ZhaoDepartment of Rheumatology, Changhai Hospital, Shanghai, China.
Weiguo WanDepartment of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
Yi LiuDepartment of Rheumatology, West China Hospital, Sichuan University, Chengdu, China.
Jianhua XuDepartment of Rheumatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jian XuDepartment of Rheumatology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Huaxiang LiuDepartment of Rheumatology, Qilu Hospital of Shandong University, Jinan, China.
Lindi JiangDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Huaxiang WuDepartment of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xiaoxia ZuoDepartment of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.
Cibo HuangDepartment of Rheumatology, Beijing Hospital, Beijing, China.
Xiumei LiuDepartment of Rheumatology, The First Affiliated Hospital of Shanxi Medical University, Taiyuan, China.
Fen LiDepartment of Rheumatology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhiyi ZhangDepartment of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiangyuan LiuDepartment of Rheumatology, Peking University Third Hospital, Beijing, China.
Lingli DongDepartment of Rheumatology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Tianwang LiDepartment of Rheumatology, Guangdong Second Provincial General Hospital, Guangzhou, China.
Haiying ChenDepartment of Rheumatology, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
Jingyang LiDepartment of Rheumatology, Zhuzhou Central Hospital, Zhuzhou, China.
Dongyi HeDepartment of Rheumatology, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.
Xin LuDepartment of Rheumatology, China-Japan Friendship Hospital, Beijing, China.
Anbin HuangDepartment of Rheumatology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Yi TaoDepartment of Rheumatology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yanyan WangDepartment of Rheumatology, Jiangsu Province Hospital, Nanjing, China.
Zhuoli ZhangDepartment of Rheumatology, Peking University First Hospital, Beijing, China.
Wei WeiDepartment of Rheumatology, Tianjin Medical University General Hospital, Tianjin, China.
Xiaofeng LiDepartment of Rheumatology, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, China.
Xiaofeng ZengDepartment of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Ministry of Science and Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNFudan University · CNShanxi Medical University · CNBeijing Hospital · CNCentral South University · CNChanghai Hospital · CNChina-Japan Friendship Hospital · CNFirst Affiliated Hospital of Kunming Medical University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNGuangdong Provincial People's Hospital · CNHebei Medical University · CNHuazhong University of Science and Technology · CNJiangsu Province Hospital · CNKunming Medical University · CNPeking Union Medical College Hospital · CNPeking University · CNPeking University First Hospital · CNPeking University Third Hospital · CNQilu Hospital of Shandong University · CNSecond Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adalimumabankylosing spondylitisHS016phase III clinical trialsubanalysis

Identifiers

PMID33364967
PMCPMC7750525
OpenAlexW3113030475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.